ES2166087T3 - Derivados de dibenzo-oxazepina y -dioxepina y su empleo como agentes antitumorales. - Google Patents

Derivados de dibenzo-oxazepina y -dioxepina y su empleo como agentes antitumorales.

Info

Publication number
ES2166087T3
ES2166087T3 ES97927080T ES97927080T ES2166087T3 ES 2166087 T3 ES2166087 T3 ES 2166087T3 ES 97927080 T ES97927080 T ES 97927080T ES 97927080 T ES97927080 T ES 97927080T ES 2166087 T3 ES2166087 T3 ES 2166087T3
Authority
ES
Spain
Prior art keywords
replaced
antitumor agents
rent
oxazepina
dioxepina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97927080T
Other languages
English (en)
Inventor
Urvashi Hooda Dhingra
Haruyoshi Shirai
Yuki Takehana
Peter Michael Wovkulich
Nami Yabuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2166087T3 publication Critical patent/ES2166087T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Rehabilitation Tools (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LOS COMPUESTOS DE FORMULA (I), EN LA QUE R1 Y R2 SON, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO INFERIOR NO SUSTITUIDO O ALQUILO INFERIOR SUSTITUIDO POR ALCOXI INFERIOR O ALQUILTIO INFERIOR, O ACILO NO SUSTITUIDO O SUSTITUIDO POR UNO O MAS DE ENTRE ALQUILO INFERIOR, ALQUILO INFERIOR SUSTITUIDO POR HALOGENO, Y ALCOXI INFERIOR; X ES CO O CHOH; Y ES CO O CH2 ; Y Z ES O O NH, Y LOS EPIMEROS Y ENANTIOMEROS DE LOS MISMOS, O LAS SALES FISIOLOGICAMENTE UTILIZABLES DE LOS MISMOS SON UTILES COMO AGENTES ANTITUMORALES. SE PUEDEN PREPARAR MEDIANTE LA FERMENTACION DE ASPERGILLUS SP. Y, OPCIONALMENTE, UNA MODIFICACION SUBSIGUIENTE DE GRUPOS FUNCIONALES.
ES97927080T 1996-06-07 1997-05-30 Derivados de dibenzo-oxazepina y -dioxepina y su empleo como agentes antitumorales. Expired - Lifetime ES2166087T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96109115 1996-06-07

Publications (1)

Publication Number Publication Date
ES2166087T3 true ES2166087T3 (es) 2002-04-01

Family

ID=8222857

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97927080T Expired - Lifetime ES2166087T3 (es) 1996-06-07 1997-05-30 Derivados de dibenzo-oxazepina y -dioxepina y su empleo como agentes antitumorales.

Country Status (30)

Country Link
US (1) US5811420A (es)
EP (1) EP0906295B1 (es)
JP (1) JP3199752B2 (es)
KR (1) KR100300152B1 (es)
CN (1) CN1072650C (es)
AT (1) ATE207471T1 (es)
AU (1) AU725649B2 (es)
BR (1) BR9709773A (es)
CA (1) CA2257422A1 (es)
CO (1) CO4940487A1 (es)
CZ (1) CZ397498A3 (es)
DE (1) DE69707672T2 (es)
DK (1) DK0906295T3 (es)
ES (1) ES2166087T3 (es)
HK (1) HK1019063A1 (es)
HR (1) HRP970313A2 (es)
HU (1) HUP0001792A3 (es)
IL (1) IL127137A0 (es)
MA (1) MA24197A1 (es)
NO (1) NO985685L (es)
NZ (1) NZ332997A (es)
PE (1) PE69598A1 (es)
PL (1) PL330346A1 (es)
PT (1) PT906295E (es)
RU (1) RU2167871C2 (es)
TR (1) TR199802517T2 (es)
UY (1) UY24578A1 (es)
WO (1) WO1997047611A1 (es)
YU (1) YU55898A (es)
ZA (1) ZA974886B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ307399A0 (en) * 1999-09-24 1999-10-21 Luminis Pty Limited Cell cycle control
CA2404540A1 (en) * 2002-09-20 2004-03-20 Institut Pasteur A method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker
US20130203715A1 (en) 2010-07-20 2013-08-08 Pulmatrix, Inc. Use of trp channel agonists to treat infections
CN109722389B (zh) * 2017-10-31 2021-05-14 鲁南新时代生物技术有限公司 一种烟曲霉菌液体培养基
CN108165590B (zh) * 2017-12-20 2021-11-23 河南科技学院 一种烟曲霉发酵产烟曲霉素的培养基及培养方法
WO2022187611A1 (en) * 2021-03-04 2022-09-09 Lifemine Therapeutics Cdk inhibitor compounds for use in methods of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120640D0 (en) * 1991-09-27 1991-11-06 Ici Plc Tricyclic heterocycles
US5350763A (en) * 1993-06-11 1994-09-27 Merck & Co., Inc. Unguinol and analogs are animal growth permittants
JPH0769882A (ja) * 1993-08-27 1995-03-14 Nippon Paint Co Ltd エプスタイン−バーウィルス活性化抑制剤
DE69429440T2 (de) * 1993-10-15 2002-08-08 Schering Corp., Kenilworth Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen

Also Published As

Publication number Publication date
CN1072650C (zh) 2001-10-10
HRP970313A2 (en) 1998-04-30
CA2257422A1 (en) 1997-12-18
MA24197A1 (fr) 1997-12-31
YU55898A (sh) 2001-12-26
KR20000016432A (ko) 2000-03-25
PL330346A1 (en) 1999-05-10
BR9709773A (pt) 1999-08-10
DE69707672T2 (de) 2002-08-08
HUP0001792A2 (hu) 2000-12-28
NO985685D0 (no) 1998-12-04
IL127137A0 (en) 1999-09-22
KR100300152B1 (ko) 2001-09-06
EP0906295A1 (en) 1999-04-07
HK1019063A1 (en) 2000-01-21
RU2167871C2 (ru) 2001-05-27
CZ397498A3 (cs) 1999-03-17
ZA974886B (en) 1997-12-08
AU725649B2 (en) 2000-10-19
US5811420A (en) 1998-09-22
HUP0001792A3 (en) 2001-10-29
PE69598A1 (es) 1998-11-14
DK0906295T3 (da) 2002-02-11
NZ332997A (en) 2000-05-26
NO985685L (no) 1999-02-04
CO4940487A1 (es) 2000-07-24
UY24578A1 (es) 2000-12-29
DE69707672D1 (de) 2001-11-29
JP3199752B2 (ja) 2001-08-20
TR199802517T2 (xx) 1999-02-22
WO1997047611A1 (en) 1997-12-18
AU3169697A (en) 1998-01-07
ATE207471T1 (de) 2001-11-15
EP0906295B1 (en) 2001-10-24
JPH11511760A (ja) 1999-10-12
CN1221409A (zh) 1999-06-30
PT906295E (pt) 2002-04-29

Similar Documents

Publication Publication Date Title
BR0012752A (pt) Benzofuril piperazinas e benzofuril homopiperazinas: agonistas de serotonina
PA8467101A1 (es) Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orli
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
DE59510421D1 (de) Substituierte Pyridylpyrazole
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ECSP941096A (es) Procedimiento para la preparacion de un derivado indol
ES2101063T3 (es) Derivados monofluorados de n-propargil-1-amino-indano y su utilizacion como inhibidores de la monoamin-oxidasa.
AR021811A1 (es) Compuestos de piridina fusionados, utiles como inhibidores de gmpc fosfodiesterasa y las composiciones farmaceuticas que las contienen.
PA8478701A1 (es) 1-(4-arilpiperazin-1-il)-omega-[n-(alpha,omega-dicarboximido)]-alcanos util como bloqueadores alpha1-adrenoceptores uro-selectivos
HN1996000017A (es) Isotiazolonas
ES2170403T3 (es) Derivados de n-bencil-piperidina y tetrahidro-piridina.
FI930772A (fi) Hydroxiureaderivat som saenker glugosnivao i blodet
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
PT799206E (pt) Derivados de aril- e heteroaril-sulfonamida processo para a sua preparacao e sua utilizacao como antagonistas da endotelina
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
ES2159922T3 (es) Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TR200201683T2 (tr) İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
ES2166087T3 (es) Derivados de dibenzo-oxazepina y -dioxepina y su empleo como agentes antitumorales.
AR025796A1 (es) Quinazolinonas
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
BR0013502A (pt) Inibidores da integrina alfav beta3
ES2029799T3 (es) Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 906295

Country of ref document: ES